What is the treatment for a ureteropelvic junction (UPJ) stone?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 31, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Ureteropelvic Junction (UPJ) Stones

Ureteroscopy (URS) or shock wave lithotripsy (SWL) should be offered as first-line therapy for ureteropelvic junction stones, with URS generally preferred due to higher stone-free rates, especially for stones >10mm. 1

Initial Assessment and Management

  • Stone characteristics to evaluate:

    • Size (stones >10mm have lower success rates with both URS and SWL)
    • Location (UPJ stones may be more difficult to visualize with ultrasound-based lithotriptors)
    • Density (harder stones may respond less well to SWL)
  • Patient factors to consider:

    • Bleeding diatheses or anticoagulation therapy (favors URS) 1
    • Pregnancy status (requires coordination with obstetrician) 1
    • Pediatric patients (both URS and SWL are effective) 1
    • Anatomical abnormalities (may influence approach)

Treatment Algorithm

First-Line Options:

  1. Ureteroscopy (URS):

    • Higher stone-free rates (95% for stones <10mm, 78% for stones >10mm) 1
    • Preferred for:
      • Larger stones (>10mm)
      • Patients on anticoagulation therapy
      • When immediate stone clearance is needed
      • Pregnant patients who fail conservative management
    • Technical considerations:
      • Safety guidewire should be used 1
      • Antimicrobial prophylaxis required 1
      • Thulium fiber laser offers higher ablation rates and superior dusting capability 2
  2. Shock Wave Lithotripsy (SWL):

    • Good stone-free rates (87% for stones <10mm, 73% for stones >10mm) 1
    • May be preferred for:
      • Small stones (<10mm)
      • Pediatric patients with difficult ureteroscopic access
      • Patients with severe scoliosis or history of ureteral reimplantation 1
    • Limitations:
      • Poor visualization of mid-ureter with ultrasound-based lithotriptors 1
      • Lower success rates for harder stones

Special Populations:

Pediatric Patients:

  • For ureteral stones ≤10mm: Initial observation with or without medical expulsive therapy (α-blockers) 1
  • For stones unlikely to pass: URS or SWL, with high success rates for both (87-95% for stones <10mm) 1
  • Pre-stenting not routinely necessary before URS 1
  • Low-dose CT scan recommended prior to percutaneous procedures 1

Pregnant Patients:

  • First-line: Observation if symptoms are well-controlled 1
  • If intervention needed: URS preferred (holmium laser has minimal tissue penetration) 2
  • Coordinate all interventions with obstetrician 1

Patients with Bleeding Disorders:

  • URS is first-line therapy for patients with uncorrected bleeding diatheses or on continuous anticoagulation 1

Complications and Management

  • If purulent urine is encountered during endoscopic intervention:

    • Abort procedure
    • Establish drainage (stent or nephrostomy)
    • Continue antibiotics
    • Obtain urine culture 1
  • Potential complications of URS with laser treatment:

    • UTIs (2-6%)
    • Ureteral injury (3-6%)
    • Ureteral stricture formation (1-5%)
    • Higher complication rates for proximal ureteral stones 2

If Initial Treatment Fails:

  • If SWL fails, endoscopic therapy (URS) should be offered next 1
  • Re-evaluate stone characteristics that may have contributed to failure
  • Success rates for URS as secondary procedure after failed SWL: 62-100% 1

Rare Scenarios:

  • Open/laparoscopic/robotic surgery should not be offered as first-line therapy except in rare cases with:

    • Anatomic abnormalities
    • Very large or complex stones
    • Need for concomitant reconstruction (e.g., UPJ obstruction repair) 1
  • Percutaneous antegrade approach may be considered for very large (>15mm) impacted stones in the proximal ureter, with stone-free rates of 85-100% 1

By following this evidence-based approach to UPJ stones, clinicians can optimize outcomes while minimizing complications and ensuring appropriate patient-specific care.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Complications of Thulium Fiber Laser Treatment for Urological Stones

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.